Serum Institute of India on Wednesday publicized that it was tumbling the price of its Covishield vaccine from Rs 400 to Rs 300 per dose for the states as a “philanthropic gesture”. “As a philanthropic gesture on behalf of Serum Institute of India, I hereby reduce the price to the states from Rs 400 to Rs 300 per dose, effective immediately, SII CEO Adar Poonawalla said on Twitter.
Making this broadcast on Twitter, Poonawalla discoursed that this will save the financial resources of state governments worth thousands of crores. Moreover, he declared that this shall help accelerate the pace of the vaccination drive and save a mammoth number of lives. While the Centre’s obtaining price for both COVISHIELD and COVAXIN remains at Rs.150 per dose, state governments and private hospitals have to purchase them at a higher cost. For instance, Bharat Biotech has offered COVAXIN at Rs.600 per dose to state governments and Rs.1200 per dose to private hospitals.
The idea is to confirm that vaccinations can be clambered up on May 1. All those aged 18 and above will be eligible to receive the life-saving jab in the third phase of the world’s largest nationwide inoculation drive starting Saturday. Earlier this month, the Serum Institute issued a clarification over the pricing of Covishield. Political leaders have advised the vaccine maker to make the jab available to all at a standard price instead of selling it to the central and state governments and private hospitals at different prices per dose.
In its statement, SII had said that only a limited number of doses of its Covid-19 vaccine will be sold to private hospitals at a cost of Rs 600. Well, we are happy to know that the vaccines will now be available at a slashed price.